Penn Medicine Abramson Cancer Center


 

ASH Updates on Lymphomas: 1L (Axi-Cel) in High-Risk DLBCL, Safety, Dosing and Feasibility of MB-CART2019 in R/R B-NHL, BTKi/mTOR/IMID Combo for R/R Richter's Transformation and De-Novo DLBCL, CNS Lymphoma Prevention, Primary CNS Lymphoma

55 views
March 2, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas